Advertisement
Canada markets open in 6 hours 12 minutes
  • S&P/TSX

    22,259.16
    -31.46 (-0.14%)
     
  • S&P 500

    5,187.67
    -0.03 (-0.00%)
     
  • DOW

    39,056.39
    +172.13 (+0.44%)
     
  • CAD/USD

    0.7282
    -0.0006 (-0.09%)
     
  • CRUDE OIL

    79.43
    +0.44 (+0.56%)
     
  • Bitcoin CAD

    84,499.18
    -1,151.46 (-1.34%)
     
  • CMC Crypto 200

    1,312.35
    +12.25 (+0.94%)
     
  • GOLD FUTURES

    2,319.60
    -2.70 (-0.12%)
     
  • RUSSELL 2000

    2,055.14
    -9.51 (-0.46%)
     
  • 10-Yr Bond

    4.4920
    +0.0290 (+0.65%)
     
  • NASDAQ futures

    18,158.00
    -28.50 (-0.16%)
     
  • VOLATILITY

    13.00
    0.00 (0.00%)
     
  • FTSE

    8,361.16
    +7.11 (+0.09%)
     
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • CAD/EUR

    0.6778
    +0.0002 (+0.03%)
     

GlaxoSmithKline ADR’s Performance and Revenues in Q3 2018

GlaxoSmithKline ADR’s Performance and Revenues in Q3 2018

GlaxoSmithKline (GSK) segregates its business portfolio into three business segments—Pharmaceuticals, Vaccines, and Consumer Healthcare. As a British multinational company, GlaxoSmithKline reports its revenues in pounds sterling. The chart below compares GlaxoSmithKline’s EPS and revenues since the first quarter of 2017, as well as its estimates for the third quarter.